Limbaroc, Rogelio B.

HRN: 27-46-06  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/11/2025
07/17/2025
IVTT
500 Mg
Q6
Tetanus Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueCentral Nervous System    Compliance to guidelines: